Antheia Raises $56 Million in Series C Financing to Fuel Global Commercialization Strategy
New funding will support the company’s rapid growth trajectory and efforts to transform pharmaceutical supply chains with its advanced biomanufacturing platform MENLO PARK, Calif., June 3, 2025 /PRNewswire/ — Antheia, the pharmaceutical ingredient manufacturer transforming essential medicine supply chains,…